Results 171 to 180 of about 517,992 (346)

Strategies to Manage Dosing Deviations and Interruptions of Cabotegravir Long‐Acting Intramuscular Injections

open access: yesClinical Pharmacology in Drug Development, EarlyView.
Abstract Long‐acting cabotegravir is approved for HIV treatment and prevention. To guide management of dosing deviations and interruptions, concentration‐time profiles for monthly and every 2 months regimens were simulated using a population pharmacokinetic (PPK) model.
Kelong Han   +3 more
wiley   +1 more source

Metastatic ganglioneuroblastoma.Ultrastructural, histochemical, and virological studies in a case [PDF]

open access: bronze, 1969
Germán Beltrán   +4 more
openalex   +1 more source

Critical Pitfalls in the Flow Cytometric Analysis of Mast Cells in Patients With Systemic Mastocytosis

open access: yesCytometry Part A, EarlyView.
ABSTRACT Systemic mastocytosis (SM) is a neoplastic disease characterized by abnormal mast cell (MC) activation and proliferation. Accurate diagnosis often relies on flow cytometry to detect aberrant CD25, CD2, and CD30 expression on MCs in bone marrow (BM).
Abdulrazzaq Alheraky   +6 more
wiley   +1 more source

OMIP‐116: A 39‐Color Full Spectrum Flow Cytometric Panel to Deeply Characterize Human Thymopoiesis

open access: yesCytometry Part A, EarlyView.
ABSTRACT We report the development of a 39‐color (43‐parameter) full spectrum flow cytometry panel designed and optimized to deeply characterize the intrathymic development of human conventional and unconventional T cells. The panel was designed using strategies dictated by best practices for full spectrum and multiparametric flow cytometry, and was ...
Simone Balin   +6 more
wiley   +1 more source

CytoNormPy Enables a Fast and Scalable Removal of Batch Effects in Cytometry Datasets

open access: yesCytometry Part A, EarlyView.
ABSTRACT Cytometry has evolved as a crucial technique in clinical diagnostics, clinical studies, and research. However, batch effects due to technical variation complicate the analysis of cytometry data in clinical and fundamental research settings and have to be accounted for.
Tarik Exner   +6 more
wiley   +1 more source

Patient‐specific modifiers of survival benefit in cardiac resynchronization therapy ‐ A multicentre interaction analysis

open access: yesESC Heart Failure, EarlyView.
Abstract Background Cardiac resynchronization therapy (CRT) is a key intervention for patients with heart failure. The choice between a CRT with defibrillator therapy (CRT‐D) and a CRT with pacemaker (CRT‐P) is influenced by individual clinical characteristics.
Bert Vandenberk   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy